Perceptive Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-719,103
Closed -$26M 102
2023
Q2
$26M Sell
719,103
-855,031
-54% -$30.9M 0.75% 42
2023
Q1
$58.5M Sell
1,574,134
-617,291
-28% -$23M 1.73% 16
2022
Q4
$99.3M Sell
2,191,425
-593,371
-21% -$26.9M 2.79% 8
2022
Q3
$194M Sell
2,784,796
-82,067
-3% -$5.73M 5.64% 2
2022
Q2
$192M Buy
2,866,863
+486,153
+20% +$32.6M 6.03% 3
2022
Q1
$196M Sell
2,380,710
-903,073
-28% -$74.3M 3.92% 6
2021
Q4
$482M Sell
3,283,783
-103,962
-3% -$15.3M 7.42% 2
2021
Q3
$599M Buy
3,387,745
+201,847
+6% +$35.7M 8.71% 1
2021
Q2
$515M Sell
3,185,898
-288,607
-8% -$46.6M 6.68% 1
2021
Q1
$595M Sell
3,474,505
-219,011
-6% -$37.5M 7.53% 1
2020
Q4
$811M Buy
3,693,516
+257,941
+8% +$56.7M 8.71% 1
2020
Q3
$570M Buy
3,435,575
+664,525
+24% +$110M 8.33% 1
2020
Q2
$316M Sell
2,771,050
-548,400
-17% -$62.6M 5.13% 5
2020
Q1
$255M Buy
3,319,450
+116,044
+4% +$8.92M 6.65% 4
2019
Q4
$413M Sell
3,203,406
-111,200
-3% -$14.3M 8.2% 2
2019
Q3
$258M Buy
3,314,606
+415,000
+14% +$32.3M 6.96% 3
2019
Q2
$299M Buy
2,899,606
+1,735,224
+149% +$179M 6.85% 3
2019
Q1
$85.3M Buy
1,164,382
+1,038,507
+825% +$76.1M 2.41% 12
2018
Q4
$5.25M Buy
+125,875
New +$5.25M 0.2% 65
2018
Q3
Sell
-713,191
Closed -$35.2M 135
2018
Q2
$35.2M Buy
713,191
+684,100
+2,352% +$33.7M 0.92% 34
2018
Q1
$893K Hold
29,091
0.03% 106
2017
Q4
$531K Buy
+29,091
New +$531K 0.02% 119
2017
Q1
Sell
-521
Closed -$2K 206
2016
Q4
$2K Buy
+521
New +$2K ﹤0.01% 168
2016
Q2
Sell
-273,000
Closed -$5.84M 198
2016
Q1
$5.84M Buy
+273,000
New +$5.84M 0.51% 47